These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3894139)

  • 1. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
    Davis TM; Bown E; Turner RC
    Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent increase in in vitro platelet sensitivity to adenosine-5'-diphosphate in young complication-free diabetic males.
    Davis TM; Bown EG; Turner RC
    Diabetes Res; 1990 Nov; 15(3):103-7. PubMed ID: 2132201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet sensitivity to prostacyclin in diabetes mellitus.
    Pillay PK; Pillay U; Balasubramaniam P; Lee KO
    Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered cellular signalling and decreased platelet sensitivity to adenosine in insulin-dependent diabetic patients with proliferative retinopathy.
    Gasser JA; Cooper MB; Tan KC; Saggerson ED; Betteridge DJ
    Cell Signal; 1993 Mar; 5(2):145-53. PubMed ID: 8499224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation in type I diabetics with and without proliferative retinopathy.
    Agardh CD; Agardh E; Bauer B
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):358-62. PubMed ID: 3618162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
    Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
    Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Vicari AM; Macagni A; Pozza G
    Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
    Jennings PE; McLaren M; Scott NA; Saniabadi AR; Belch JJ
    Diabet Med; 1991 Nov; 8(9):860-5. PubMed ID: 1837513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet shape change abnormalities in diabetic retinopathy.
    Porta M; Hilgard P; Kohner EM
    Diabetologia; 1980 Mar; 18(3):217-21. PubMed ID: 7372026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
    Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
    Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation in experimental diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Diabetes; 1984 Sep; 33(9):846-50. PubMed ID: 6381180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography.
    Silberbauer K; Schernthaner G; Sinzinger H; Freyler H
    Atherosclerosis; 1981; 40(1):81-90. PubMed ID: 7284054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low concentrations of prostacyclin on platelet function in vitro.
    van Heerden PV; Gibbs NM; Michalopoulos N
    Anaesth Intensive Care; 1997 Aug; 25(4):343-6. PubMed ID: 9288373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation in diabetic retinopathy.
    Creter D; Pavlotzky F; Savir H
    Acta Haematol; 1978; 60(1):53-5. PubMed ID: 97900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Tohoku J Exp Med; 1984 Jun; 143(2):161-9. PubMed ID: 6474447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.
    Coller BS; Frank RN; Milton RC; Gralnick HR
    Ann Intern Med; 1978 Mar; 88(3):311-6. PubMed ID: 305223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.